Alimentation and Diabetes in Lanzarote - ADILAN: a Pilot Trial
ADILAN
1 other identifier
interventional
14
1 country
1
Brief Summary
The purpose of this study is to compare two healthy diets (according to official Spanish guidelines) that have been shown to be effective in the treatment of type 2 diabetes in order to see if one is better than the other. Another goal is to test the hypothesis that food choice has metabolic effects that are independent of macro/micronutrient composition, fiber content, glycemic load and weight loss in the treatment of type 2 diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable type-2-diabetes
Started Nov 2013
Shorter than P25 for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 28, 2013
CompletedFirst Posted
Study publicly available on registry
July 3, 2013
CompletedStudy Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedMarch 21, 2014
March 1, 2014
3 months
June 28, 2013
March 20, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Fasting fructosamine
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Fasting glucagon
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Secondary Outcomes (18)
Area under the curve for glucose (AUC glucose0-120) at the oral glucose tolerance test
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Area under the curve for glucagon (AUC glucagon0-120) at the oral glucose tolerance test
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Fasting plasma glucose
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Total cholesterol
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Low-density lipoprotein (LDL) cholesterol
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
- +13 more secondary outcomes
Study Arms (2)
Diet A
ACTIVE COMPARATORHealthy diet with grains and dairy
Diet B
ACTIVE COMPARATORHealthy diet without grains and dairy
Interventions
Healthy diet A will include fruit, vegetables, fish, shellfish, lean meat, nuts, eggs and olive oil. Macro/micronutrient composition, fiber intake and glycemic load will not differ from healthy diet B. Healthy diet A will include substantial amounts of whole grains, low-fat dairy and legumes (this is called "healthy diet with grains and dairy"). This diet is classified as very healthy using validated nutritional software. It is in accordance with official Spanish dietary recommendations for people with diabetes type 2 regarding macronutrient composition, dietary fiber, minerals and vitamins.
Healthy diet B will include fruit, vegetables, fish, shellfish, lean meat, nuts, eggs and olive oil. Macro/micronutrient composition, fiber intake and glycemic load will not differ from healthy diet A. Healthy diet B will exclude grains, legumes and dairy, which will largely be replaced by root vegetables, vegetables and fruit, and slightly more lean meat, fish and nuts (this is called "healthy diet without grains and dairy"). Salt intake will be lower in healthy diet B. This diet is classified as very healthy using validated nutritional software. It is in accordance with official Spanish dietary recommendations for people with diabetes type 2 regarding macronutrient composition, dietary fiber, minerals and vitamins.
Eligibility Criteria
You may qualify if:
- Medical diagnosis of type 2 diabetes
- Increased waist circumference (≥80 cm for women and ≥94 cm for men)
- Unaltered medical diabetes treatment since three months before start of study
- Stable weight (varied less than 5%) since three months before start of study
- HbA1c ≥6.0%
You may not qualify if:
- Creatinine \>130 μmol/L
- Change of treatment with betablocker last 3 months
- Change of treatment with thyroid hormone substitution last 3 months
- Treatment with anticoagulant medication
- Oral or injected steroid treatment
- Elevated liver enzymes (AST, ALT, ALP, GPT \> 4 times their respective upper reference value)
- Physical or psychical illness, or changes in personal circumstances that make it impossible for the patient to continue in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lund Universitylead
- Cabildo de Lanzarotecollaborator
- Ayuntamiento de Teguisecollaborator
- Ayuntamiento de Arrecifecollaborator
Study Sites (1)
Hospital Insular de Lanzarote
Arrecife, Las Palmas, 35500, Spain
Related Publications (6)
Nield L, Moore HJ, Hooper L, Cruickshank JK, Vyas A, Whittaker V, Summerbell CD. Dietary advice for treatment of type 2 diabetes mellitus in adults. Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD004097. doi: 10.1002/14651858.CD004097.pub4.
PMID: 17636747BACKGROUNDAjala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr. 2013 Mar;97(3):505-16. doi: 10.3945/ajcn.112.042457. Epub 2013 Jan 30.
PMID: 23364002BACKGROUNDJonsson T, Granfeldt Y, Ahren B, Branell UC, Palsson G, Hansson A, Soderstrom M, Lindeberg S. Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study. Cardiovasc Diabetol. 2009 Jul 16;8:35. doi: 10.1186/1475-2840-8-35.
PMID: 19604407BACKGROUNDLindeberg S, Jonsson T, Granfeldt Y, Borgstrand E, Soffman J, Sjostrom K, Ahren B. A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease. Diabetologia. 2007 Sep;50(9):1795-1807. doi: 10.1007/s00125-007-0716-y. Epub 2007 Jun 22.
PMID: 17583796BACKGROUNDJonsson T, Olsson S, Ahren B, Bog-Hansen TC, Dole A, Lindeberg S. Agrarian diet and diseases of affluence--do evolutionary novel dietary lectins cause leptin resistance? BMC Endocr Disord. 2005 Dec 10;5:10. doi: 10.1186/1472-6823-5-10.
PMID: 16336696BACKGROUNDFontes-Villalba M, Jonsson T, Granfeldt Y, Frassetto LA, Sundquist J, Sundquist K, Carrera-Bastos P, Fika-Hernando M, Picazo O, Lindeberg S. A healthy diet with and without cereal grains and dairy products in patients with type 2 diabetes: study protocol for a random-order cross-over pilot study--Alimentation and Diabetes in Lanzarote--ADILAN. Trials. 2014 Jan 2;15:2. doi: 10.1186/1745-6215-15-2.
PMID: 24383431DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student
Study Record Dates
First Submitted
June 28, 2013
First Posted
July 3, 2013
Study Start
November 1, 2013
Primary Completion
February 1, 2014
Study Completion
February 1, 2014
Last Updated
March 21, 2014
Record last verified: 2014-03